September 2026 Webinar

Paneez Khoury

Dr. Paneez Khoury is Senior Clinician and Investigator in the Human Eosinophil Section of the NIH where she is involved in clinical and translational research.  She has served as a principal investigator on natural history, sponsored, and investigator-initiated protocols for a variety of eosinophilic disorders including hypereosinophilic syndromes (HES), eosinophilic granulomatosis with polyangiitis (EGPA), eosinophilic gastrointestinal disorders (EGIDs), episodic angioedema with eosinophilia, and has been involved in the development of outcome metrics and guidelines for patients with a variety of eosinophilic disorders. She is also the Program Director for the Allergy & Immunology fellowship training program at NIH in the Laboratory of Allergic Diseases where she designs curriculum and programs for education, mentorship and sponsorship of fellows-in-training. 

Alexandra Nanzer

Dr Alexandra Nanzer, PhD, is a Consultant in Severe Asthma and Eosinophilic Lung Diseases at Guy’s Hospital and a Senior Lecturer at King’s College London, where she previously obtained her PhD in asthma immunology.

She leads an EGPA clinic jointly with colleagues in respiratory, rheumatology, ENT and cardiology and cares for the largest EGPA patient cohort on biologic therapies in the UK. Her expertise in biologic therapies for patients with severe asthma, EGPA and associated eosinophilic lung diseases has been published in peer reviewed journals and book chapters over the past years.

Philip Seo

Dr. Philip Seo is an Associate Professor of Medicine at Johns Hopkins University, an Adjunct Professor of Medicine at the University of Maryland, and Rheumatology Physician Editor for UpToDate. He was the Director of the Johns Hopkins Vasculitis Center and the Director of the Johns Hopkins Rheumatology Fellowship Training Program for 11 years, and is a voting member of the American College of Rheumatology's Vasculitis Guidelines Taskforce.

Praveen Akuthota

Dr. Akuthota’s research efforts range from basic scientific investigations of human eosinophil biology and eosinophilic inflammation to clinical and translational efforts in asthma and eosinophilic pulmonary disease. He is the PI for the San Diego Clinical Center in the NHLBI PrecISE Network that is studying precision interventions in severe asthma. His research group is involved in other multicenter studies in eosinophilic disease and asthma. He has written several reviews and chapters discussing eosinophil immunobiology and clinical considerations in eosinophilic diseases.

Michael Wechsler

Michael E. Wechsler is Professor of Medicine in the Division of Pulmonary, Critical Care and Sleep Medicine at NJH in Denver, Director of the National Jewish Health (NJH)/Cohen Family Asthma Institute and Associate Vice President for Innovation and Industry Relations at NJH. In addition to clinical work in pulmonary & critical care medicine, Professor Wechsler’s research focuses on clinical and translational asthma with emphasis on clinical trials in asthma, novel asthma therapies, bronchial thermoplasty, asthma pharmacogenomics, and management of eosinophilic granulomatosis with polyangiitis (i.e. Churg-Strauss Syndrome, CSS). He has led studies focusing on novel biologic agents for asthma and related diseases, including benralizumab, dupilumab, mepolizumab, reslizumab, and tezepelumab. He has published more than 250 peer-reviewed manuscripts relating to asthma, EGPA and eosinophilic lung diseases. He was a member of the Steering Committee and site Principal Investigator of the NIH-sponsored Asthma Clinical Research Network (ACRN, now called AsthmaNet), a multicentre asthma clinical trials consortium, and currently serves as the PI of the Denver site of the Precision Intervention in Severe/Exacerbating Asthma (PRECISE) network. A member of the American Society of Clinical Investigation and the Association of American Physicians, he has participated in many different task forces related to the study of eosinophilic lung diseases that were sponsored by the NIH, the FDA, the European Respiratory Society and the International Eosinophil Society. He is currently Associate Editor of the journal Chest and has served as Associate Editor of the journal Allergy and on the editorial board of the European Journal of Clinical Investigation.
Dr. Wechsler received AB and MMSc degrees from Harvard University in Boston and an MD degree from McGill University in Montreal. He completed medical training at Beth Israel Hospital in Boston, and as part of the Harvard Combined Pulmonary and Critical Care Fellowship Training Program.